Gastroparesis in type 2 diabetes mellitus: prevalence, etiology, diagnosis, and treatment.
A Type 2 Diabetes Mellitus Patient With Severe Diabetic Gastroparesis Successfully Treated With Intravenous Erythromycin.
Risk factor analysis and nomogram for predicting gastroparesis in patients with type 2 diabetes mellitus.
Euglycemic diabetic ketoacidosis: A missed diagnosis.
Nasa P, Chaudhary S, Shrivastava PK, Singh A.
World J Diabetes. 2021 May 15;12(5):514-523. doi: 10.4239/wjd.v12.i5.514.
Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide.
Jalleh RJ, Plummer MP, Marathe CS, Umapathysivam MM, Quast DR, Rayner CK, Jones KL, Wu T, Horowitz M, Nauck MA.
J Clin Endocrinol Metab. 2024 Dec 18;110(1):1-15. doi: 10.1210/clinem/dgae719.
Glucagon-Like Peptide-1 Receptor Agonists and Gastrointestinal Adverse Events: A Systematic Review and Meta-Analysis.
Chiang CH, Jaroenlapnopparat A, Colak SC, Yu CC, Xanthavanij N, Wang TH, See XY, Lo SW, Ko A, Chang YC, Song J, Hsia YP, Chiang CH.
Gastroenterology. 2025 Nov;169(6):1268-1281. doi: 10.1053/j.gastro.2025.06.003. Epub 2025 Jun 9.
Gastroparesis.
Tack J, Carbone F, Rotondo A.
Curr Opin Gastroenterol. 2015 Nov;31(6):499-505. doi: 10.1097/MOG.0000000000000220.
Perioperative management of long-acting glucagon-like peptide-1 (GLP-1) receptor agonists: concerns for delayed gastric emptying and pulmonary aspiration.
van Zuylen ML, Siegelaar SE, Plummer MP, Deane AM, Hermanides J, Hulst AH.
Br J Anaesth. 2024 Apr;132(4):644-648. doi: 10.1016/j.bja.2024.01.001. Epub 2024 Jan 29.
Diabetic gastroparesis.
Koch KL, Calles-Escandón J.
Gastroenterol Clin North Am. 2015 Mar;44(1):39-57. doi: 10.1016/j.gtc.2014.11.005.
Comparative Gastrointestinal Safety of Dulaglutide, Semaglutide, and Tirzepatide in Adults With Type 2 Diabetes.
Crisafulli S, Alkabbani W, Paik JM, Bykov K, Tavakkoli A, Glynn RJ, Htoo PT, Yu EW, Trifirò G, Wexler DJ, Patorno E.
Ann Intern Med. 2026 Jan;179(1):1-11. doi: 10.7326/ANNALS-25-01724. Epub 2025 Nov 4.
Diabetic nephropathy.
Ritz E.
Saudi J Kidney Dis Transpl. 2006 Dec;17(4):481-90.
Risks of peri- and postoperative complications with glucagon-like peptide-1 receptor agonists.
Klonoff DC, Kim SH, Galindo RJ, Joseph JI, Garrett V, Gombar S, Aaron RE, Tian T, Kerr D.
Diabetes Obes Metab. 2024 Aug;26(8):3128-3136. doi: 10.1111/dom.15636. Epub 2024 May 14.
Glucagon-like Peptide-1 Receptor Agonists Associated Gastrointestinal Adverse Events: A Cross-Sectional Analysis of the National Institutes of Health All of Us Cohort.
Aldhaleei WA, Abegaz TM, Bhagavathula AS.
Pharmaceuticals (Basel). 2024 Feb 2;17(2):199. doi: 10.3390/ph17020199.
